193 related articles for article (PubMed ID: 24107765)
1. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study.
Wu CS; Lin CC; Chang CM; Wu KY; Liang HY; Huang YW; Tsai HJ
J Clin Psychiatry; 2013 Sep; 74(9):918-24. PubMed ID: 24107765
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD.
Ishiguro C; Wang X; Li L; Jick S
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1168-75. PubMed ID: 25195779
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.
Schmedt N; Garbe E
J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055
[TBL] [Abstract][Full Text] [Related]
4. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
Lacut K; Le Gal G; Couturaud F; Cornily G; Leroyer C; Mottier D; Oger E
Fundam Clin Pharmacol; 2007 Dec; 21(6):643-50. PubMed ID: 18034665
[TBL] [Abstract][Full Text] [Related]
5. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
[TBL] [Abstract][Full Text] [Related]
6. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case-control study.
Wang MT; Liou JT; Huang YW; Lin CW; Wu GJ; Chu CL; Yeh CB; Wang YH
Thromb Haemost; 2016 Jun; 115(6):1209-19. PubMed ID: 26941052
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.
Parker C; Coupland C; Hippisley-Cox J
BMJ; 2010 Sep; 341():c4245. PubMed ID: 20858909
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study.
Wu CS; Chang CM; Tsai YT; Huang YW; Tsai HJ
J Clin Psychiatry; 2015 Sep; 76(9):1216-23. PubMed ID: 26115407
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotics and venous thromboembolism risk: a meta-analysis.
Zhang R; Dong L; Shao F; Tan X; Ying K
Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
[TBL] [Abstract][Full Text] [Related]
10. Risk of venous thromboembolism during treatment with antipsychotic agents.
Masopust J; Malý R; Vališ M
Psychiatry Clin Neurosci; 2012 Dec; 66(7):541-52. PubMed ID: 23252920
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.
Liperoti R; Pedone C; Lapane KL; Mor V; Bernabei R; Gambassi G
Arch Intern Med; 2005 Dec 12-26; 165(22):2677-82. PubMed ID: 16344428
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
Ray JG; Mamdani MM; Yeo EL
Thromb Haemost; 2002 Aug; 88(2):205-9. PubMed ID: 12195690
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study.
Ferraris A; Szmulewicz AG; Posadas-Martínez ML; Serena MA; Vazquez FJ; Angriman F
J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509358
[TBL] [Abstract][Full Text] [Related]
14. Association between antidepressants and venous thromboembolism in Taiwan.
Wu CS; Chang CM; Chen CY; Wu EC; Wu KY; Liang HY; Chao YL; Chung WS; Tsai HJ
J Clin Psychopharmacol; 2013 Feb; 33(1):31-7. PubMed ID: 23277236
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of venous thromboembolism within the first year after Staphylococcus aureus bacteraemia: a nationwide observational matched cohort study.
Mejer N; Westh H; Schønheyder HC; Jensen AG; Larsen AR; Skov R; Benfield T;
J Intern Med; 2014 Apr; 275(4):387-97. PubMed ID: 24118528
[TBL] [Abstract][Full Text] [Related]
16. Risk of acute coronary syndrome in elderly users of antipsychotic drugs: a nested case-control study.
Kleijer BC; Koek HL; van Marum RJ; Jansen PA; Egberts TC; Heerdink ER
Heart; 2012 Aug; 98(15):1166-71. PubMed ID: 22689716
[TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotics and risk of cerebrovascular events in schizophrenic patients: a nested case-control study.
Hsieh PH; Hsiao FY; Gau SS; Gau CS
J Clin Psychopharmacol; 2013 Jun; 33(3):299-305. PubMed ID: 23609396
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic drugs and fatal pulmonary embolism.
Parkin L; Skegg DC; Herbison GP; Paul C
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):647-52. PubMed ID: 14762980
[TBL] [Abstract][Full Text] [Related]
19. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Sundström A; Seaman H; Kieler H; Alfredsson L
BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolism due to antipsychotic drug therapy.
Hägg S; Jönsson AK; Spigset O
Expert Opin Drug Saf; 2009 Sep; 8(5):537-47. PubMed ID: 19569978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
